The store will not work correctly when cookies are disabled.
(2,5-dioxopyrrolidin-1-yl)4-phenylbenzenesulfonate
ID: ALA4855230
PubChem CID: 21715540
Max Phase: Preclinical
Molecular Formula: C16H13NO5S
Molecular Weight: 331.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCC(=O)N1OS(=O)(=O)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C16H13NO5S/c18-15-10-11-16(19)17(15)22-23(20,21)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2
Standard InChI Key: MNBBOLNLMNXWFK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
37.0584 -9.3853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.8479 -8.5970 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
36.2705 -9.1735 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3963 -9.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2135 -9.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4679 -8.3032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8049 -7.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1461 -8.3032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8036 -7.0039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.6930 -9.7416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.2454 -8.0518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6295 -8.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2318 -8.9024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0128 -8.6539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1885 -7.8518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5771 -7.2985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7985 -7.5499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9665 -7.6025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5713 -8.1537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3490 -7.9051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5230 -7.1058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9132 -6.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1379 -6.8069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
7 9 2 0
5 10 2 0
6 11 1 0
11 2 1 0
2 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
15 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.35 | Molecular Weight (Monoisotopic): 331.0514 | AlogP: 2.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.40 | CX LogD: 2.40 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.80 | Np Likeness Score: -0.56 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |